Annual Working Capital
$81.72 M
-$27.49 M-25.17%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual working capital is $81.72 million, with the most recent change of -$27.49 million (-25.17%) on December 31, 2023.
- During the last 3 years, TRVI annual working capital has risen by +$41.01 million (+100.72%).
- TRVI annual working capital is now -25.17% below its all-time high of $109.22 million, reached on December 31, 2022.
Performance
TRVI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$58.21 M
-$7.16 M-10.96%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly working capital is $58.21 million, with the most recent change of -$7.16 million (-10.96%) on September 30, 2024.
- Over the past year, TRVI quarterly working capital has dropped by -$23.51 million (-28.77%).
- TRVI quarterly working capital is now -48.34% below its all-time high of $112.68 million, reached on September 30, 2022.
Performance
TRVI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TRVI Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -25.2% | -28.8% |
3 y3 years | +100.7% | +179.9% |
5 y5 years | +1229.3% | -3.8% |
TRVI Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -25.2% | +223.9% | -48.3% | +243.0% |
5 y | 5-year | -25.2% | +223.9% | -48.3% | +243.0% |
alltime | all time | -25.2% | +1229.3% | -48.3% | +846.9% |
Trevi Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $58.21 M(-11.0%) |
Jun 2024 | - | $65.38 M(-8.6%) |
Mar 2024 | - | $71.49 M(-12.5%) |
Dec 2023 | $81.72 M(-25.2%) | $81.72 M(-7.9%) |
Sep 2023 | - | $88.78 M(-6.1%) |
Jun 2023 | - | $94.50 M(-6.4%) |
Mar 2023 | - | $101.00 M(-7.5%) |
Dec 2022 | $109.22 M(+332.8%) | $109.22 M(-3.1%) |
Sep 2022 | - | $112.68 M(+74.8%) |
Jun 2022 | - | $64.45 M(+279.8%) |
Mar 2022 | - | $16.97 M(-32.7%) |
Dec 2021 | $25.23 M | $25.23 M(+21.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $20.79 M(-28.5%) |
Jun 2021 | - | $29.07 M(-21.1%) |
Mar 2021 | - | $36.82 M(-9.6%) |
Dec 2020 | $40.71 M(-25.1%) | $40.71 M(-17.1%) |
Sep 2020 | - | $49.11 M(+24.1%) |
Jun 2020 | - | $39.57 M(-15.1%) |
Mar 2020 | - | $46.61 M(-14.2%) |
Dec 2019 | $54.35 M(+784.1%) | $54.35 M(-10.2%) |
Sep 2019 | - | $60.51 M(-10.4%) |
Jun 2019 | - | $67.50 M(+508.2%) |
Mar 2019 | - | $11.10 M(+80.5%) |
Dec 2018 | $6.15 M(-59.1%) | $6.15 M |
Dec 2017 | $15.04 M | - |
FAQ
- What is Trevi Therapeutics annual working capital?
- What is the all time high annual working capital for Trevi Therapeutics?
- What is Trevi Therapeutics annual working capital year-on-year change?
- What is Trevi Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly working capital year-on-year change?
What is Trevi Therapeutics annual working capital?
The current annual working capital of TRVI is $81.72 M
What is the all time high annual working capital for Trevi Therapeutics?
Trevi Therapeutics all-time high annual working capital is $109.22 M
What is Trevi Therapeutics annual working capital year-on-year change?
Over the past year, TRVI annual working capital has changed by -$27.49 M (-25.17%)
What is Trevi Therapeutics quarterly working capital?
The current quarterly working capital of TRVI is $58.21 M
What is the all time high quarterly working capital for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly working capital is $112.68 M
What is Trevi Therapeutics quarterly working capital year-on-year change?
Over the past year, TRVI quarterly working capital has changed by -$23.51 M (-28.77%)